Nuffield Health Cheltenham Hospital joins the growing number of independent hospitals across the UK in offering suitable early stage breast cancer patients the choice of single dose Intraoperative radiotherapy (SD-IORT) by utilising the ORL managed service.
Experienced consultant breast surgeons Charlie Chan, Fiona Court and James Bristol will be offering IORT at Nuffield Health Cheltenham Hospital. Patients who would benefit from SD-IORT include those that are 50 years or older with small low-grade tumours. SD-IORT has considerable benefits for the patient in comparison to whole breast radiotherapy. For most patients, SD-IORT eliminates the need for post-operative radiotherapy, avoiding the inconvenience, disruption and expense of attending daily hospital appointments for several weeks.
The ORL managed service enables hospitals throughout the UK to offer IORT to eligible patients without the need to travel long distances for treatment. ORL aims to bring managed mobile services closer to the patients.
ORL use the Xoft Axxent Electronic Brachytherapy (eBx) System to deliver SD-IORT during breast-conserving surgery (BCS) to treat early stage breast cancer.